Kalliolias, George

Publications

Sort by

Co-Author Network

selected publications

Targeting TLR Signaling Cascades in Systemic Lupus Erythematosus and Rheumatoid Arthritis: An Update. Biomedicines. 2024 Academic Article GET IT
How to improve translatability and clinical relevance of preclinical studies in rheumatoid arthritis. Immunology. 2023 Academic Article GET IT
Solid Cancers and Rheumatoid Arthritis. Cancers. 2023 Editorial Article GET IT
Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non-Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis. The Journal of investigative dermatology. 2022 Academic Article GET IT
Augmenting MNK1/2 activation by c-FMS proteolysis promotes osteoclastogenesis and arthritic bone erosion. Bone research. 2021 Academic Article GET IT
Times cited: 6
Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first-in-human and first-in-patient trials. Clinical and translational science. 2021 Academic Article GET IT
Times cited: 14
RA-map: building a state-of-the-art interactive knowledge base for rheumatoid arthritis. Database : the journal of biological databases and curation. 2020 Academic Article GET IT
Times cited: 20
TNF-induced inflammatory genes escape repression in fibroblast-like synoviocytes: transcriptomic and epigenomic analysis. Annals of the rheumatic diseases. 2019 Academic Article GET IT
Times cited: 67
Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nature communications. 2018 Academic Article GET IT
Times cited: 333
Computational Systems Biology Approach for the Study of Rheumatoid Arthritis: From a Molecular Map to a Dynamical Model. Genomics and computational biology. 2017 Academic Article GET IT
Times cited: 54
Tumor Necrosis Factor dynamically regulates the mRNA stabilome in rheumatoid arthritis fibroblast-like synoviocytes. PloS one. 2017 Academic Article GET IT
Times cited: 19
The impact of disease activity and tumour necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis. Clinical and experimental immunology. 2016 Academic Article GET IT
Times cited: 39
Prolonged tumor necrosis factor α primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin. Arthritis & rheumatology (Hoboken, N.J.). 2015 Academic Article GET IT
Times cited: 59
Modulation of TNF-induced macrophage polarization by synovial fibroblasts. Journal of immunology (Baltimore, Md. : 1950). 2014 Academic Article GET IT
Times cited: 77
Kinase inhibitors: a new tool for the treatment of rheumatoid arthritis. Clinical immunology (Orlando, Fla.). 2013 Information Resource GET IT
Times cited: 27
Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts. Arthritis and rheumatism. 2013 Academic Article GET IT
Times cited: 115
iRHOM2 is a critical pathogenic mediator of inflammatory arthritis. The Journal of clinical investigation. 2013 Academic Article GET IT
Times cited: 139
The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment. Arthritis and rheumatism. 2012 Academic Article GET IT
Times cited: 51
Churg-strauss syndrome with eosinophilic myocarditis: a clinical pathology conference held by the division of rheumatology at hospital for special surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2012 Academic Article GET IT
Times cited: 4
Suppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27. Journal of immunology (Baltimore, Md. : 1950). 2010 Academic Article GET IT
Times cited: 67
A new tool for detection of type I interferon activation in systemic lupus erythematosus. Arthritis research & therapy. 2010 Editorial Article GET IT
Times cited: 5
Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins. Immunity. 2010 Academic Article GET IT
Times cited: 118
Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling. Arthritis and rheumatism. 2010 Academic Article GET IT
Times cited: 79
Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proceedings of the National Academy of Sciences of the United States of America. 2010 Academic Article GET IT
Times cited: 121
Targeting cytokines in inflammatory diseases: focus on interleukin-1-mediated autoinflammation. F1000 biology reports. 2009 Academic Article GET IT
Times cited: 58
Effect of epoetin alpha therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy. European journal of cancer care. 2008 Academic Article GET IT
Times cited: 23
IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38. Journal of immunology (Baltimore, Md. : 1950). 2008 Academic Article GET IT
Times cited: 93
The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis. Expert opinion on investigational drugs. 2008 Information Resource GET IT
Times cited: 73
Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial. Annals of the rheumatic diseases. 2007 Article GET IT
Times cited: 80
Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease. Rheumatology international. 2006 Academic Article GET IT
Times cited: 43
Hippocrates and genomic medicine. Archives of medical research. 2006 Academic Article GET IT
Times cited: 6
Of temples and plane trees: the Hippocratic legacy as collective memory. Hormones (Athens, Greece). 2005 Academic Article GET IT
Times cited: 1

more ...

less ...

Background

education and training

M.D., University of Patras Faculty of Medicine (Greece) 96
Ph.D., University of Patras Faculty of Medicine (Greece) 2009
B.A., University of Patras (Greece) 2005

Contact

full name

George Kalliolias

primary email

gek3001@med.cornell.edu

VIVO Weill Cornell Medical College

George Kalliolias Assistant Professor of Medicine (Courtesy)

Publications

selected publications

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email